734 results about "Aryl radical" patented technology

This invention provides a kind of magnesium halide adducts, whose general chemical formula is MgX2-mROH-nE-pH2O (I), wherein, X is Cl or Br; R is C1-C12 alkyl, C3-C10 cycloalkyl or C6-C10 aryl; E is dialkoxy hydrocarbon compound as shown in formula (II); m is 1-5; n is 0.005-1.0; p is 0-0.8. In formula (II), R1, R2, R3 and R4 are the same or different, and are H or C1-C10 linear or branched alkyl, C3-C10 cycloalkyl, C6-C10 aryl, C7-C10 alkylaryl or arylalkyl; two or more groups of R1 and R2 can bond into one or several fused rings; H is aryl or alkylaryl or H in benzene ring of arylalkyl can be substituted by halogen.

The invention provides substituted diaryl compounds as shown in general formula (I) or their pharmaceutically acceptable salts, and also provides a preparation method; a class of novel broad-spectrum antiviral compounds and pharmaceutical salts targeting cytokines are screened and obtained through studies on structure-activity relationship and action mechanism of active compounds; the compounds not only have significant broad-spectrum antiviral activity, but also have the advantages of low toxicity and good pharmaceutical properties.

A method is provided for treating androgen receptor-associated conditions such as age-related diseases, for example sarcopenia, employing a compound of the structure wherein R1 is CN or H; X is O or S;R2 is alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl; R3 and R4 are the same or different and are independently selected from H, C(O)R2a, alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl; R2a is alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl; G is aryl or heteroaryl, or aryl or heteroaryl substituted with one, two, three, four or five, where possible, of the substituents selected from the group consisting of hydrogen (H), halo, NO2, CN, OR2b, OH, CF3, NR3aR4a; wherein R3a and R4a, and R2b are the same or different and are independently selected from alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl and substituted heteroaryl; or a pharmaceutically acceptable salt thereof and a prodrug ester thereof.

Fumaric acid amides of the general formula (I)wherein R1 represents OR3 or a D- or L-amino acid radical —NH—CHR4—COOH bonded via an amide bond, wherein R3 is hydrogen, a straight-chained or branched, optionally substituted C1-24 alkyl radical, a phenyl radical or C6-10 aralkyl radical and R4 is a side chain of a natural or synthetic amino acid and R2 represents a D- or L-amino acid radical —NH—CHR5—COOH bonded via an amide bond or a peptide radical comprising 2 to 100 amino acids bonded via an amide bond, wherein R5 is a side chain of a natural or synthetic amino acid, are used for preparing a drug (1) for the therapy of an autoimmune disease; (2) for use in transplantation medicine; (3) for the therapy of mitochondrial diseases; or (4) for the therapy of NF-kappaB mediated diseases.

Provided are an anthracene derivative having a heteroaryl group containing a nitrogen-containing six-membered ring and having a specific structure and an organic electroluminescence device in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is interposed between a cathode and an anode, wherein at least one layer in the above organic thin film layer contains the anthracene derivative described above in the form of a single component or a mixed component. Provided are the organic electroluminescence device in which homogeneous light emission is obtained over a long period of time and which has a long lifetime and the anthracene derivative which materializes the same.

Compounds, compositions and methods that are useful for the treatment of metabolic disorders, inflammatory diseases and cancer are provided herein. In particular, the invention provides compounds which modulate the expression and / or function of proteins involved in lipid metabolism, inflammation and cell proliferation. The subject compounds are linked biaryl compounds.

Disclosed is a thermoplastic composition comprising a mixture of from 10 to 98 weight % of a polycarbonate polymer, from 2 to 90 weight % of a polyester polymer comprising structures derived from a diol compound having the structure (A) HO-Z-OH, wherein Z is a C1 to C36 linear aliphatic radical, a C3 to C36 branched aliphatic or cycloaliphatic radical, a C6 to C36 aryl radical, or a C7 to C36 alkylaryl radical, and a diacid compound having the structure (B) HOOC—CH2CH2—COOH, from 0 to 5 weight % of a polylactic acid polymer, wherein the sum of the polycarbonate polymer, the polyester polymer, and the polylactic acid polymer is equal to 100 weight %. The thermoplastic composition has improved mechanical properties.

Methods are disclosed of making linear and cross-linked, HMW (high molecular weight) polysilanes and polygermanes, polyperhydrosilanes and polyperhydrogermanes, functional liquids containing the same, and methods of using the liquids in a range of desirable applications. The silane and germane polymers are generally composed of chains of Si and / or Ge substituted with R′ substituents, where each instance of R′ is, for example, independently hydrogen, halogen, alkenyl, alkynyl, hydrocarbyl, aromatic hydrocarbyl, heterocyclic aromatic hydrocarbyl, SiR″3, GeR″3, PR″2, OR″, NR″2, or SR″; where each instance of R″ is independently hydrogen or hydrocarbyl. The cross-linked polymers can be synthesized by dehalogenative coupling or dehydrocoupling. The linear polymers can be synthesized by ring-opening polymerization. The polymers can be further modified by halogenation and / or reaction with the source of hydride to furnish perhydrosilane and perhydrogermane polymers, which are used in liquid ink formulations. The synthesis allows for tuning of the liquid properties (e.g., viscosity, volatility, and surface tension). The liquids can be used for deposition of films and bodies by spincoating, inkjetting, dropcasting, etc., with or without the use of UV irradiation. The deposited films can be converted into amorphous and polycrystalline silicon or germanium, and silicon or germanium oxide or nitride by curing at 400-600 DEG C. and (optionally) laser- or heat-induced crystallization (and / or dopant activation, when dopant is present).

A polymer comprising recurring units of a sulfonium salt represented by formula (1) is provided as well as a chemically amplified resist composition comprising the same. R1 is H, F, methyl or trifluoromethyl, R2 to R4 are C1-C10 alkyl or alkoxy, R5 is C1-C30 alkyl or C6-C14 aryl, k, m and n are 0 to 3. The recurring units generate a sulfonic acid upon exposure to high-energy radiation so as to facilitate effective scission of acid labile groups in the resist composition. The resist composition exhibits excellent resolution and a pattern finish with minimal LER.

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

The invention discloses a C3 / C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain as well as a preparation method and an application thereof. The C3 / C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain is a compound which has the following structural general formula (I), wherein R1 and R1' are independently selected from H, (C1-C10) alkyl, (C3)-(C10) cycloalkyl, (C1)-(C10) haloalkyl and substituted aryl group or substituted heterocyclic aryl group; R2 and R2' are independently selected from H, (C1-C7)alkyl, (C3)-(C7) cycloalkyl, substituted aryl group, substituted heterocyclic aryl group and hydrocarbon acyl or sulfonyl; R3 and R3' are independently selected from H, (C1-C5) alkyl, (C3)-(C5) cycloalkyl, substituted aryl radical or substitutionalheterocyclic aryl radical; and X and Y are independently selected from CH, N or carbon atoms connected with halogen, alkyl, oxyl, sulfenyl, amino, substituted amino, substituted aryl radical or substituted heterocyclic aryl radical. The C3 / C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain can be used for preparing medicaments for treating tumors and preventing microbialinfection diseases.

Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

The present invention relates to reactive compositions containing A) one or more blocked polyurethane prepolymers which have a content of blocked isocyanate groups (calculated as NCO) of 0.1 to 20 wt. % and are prepared from i) at least one aromatic, aliphatic, araliphatic and / or cycloaliphatic diisocyanate having a content of free NCO groups of 5 to 60 wt. %, ii) a polyol component containing at least one polyester polyol, and / or at least one polyether polyol and / or at least one polycarbonate polyol, iii) CH-acidic cyclic ketones corresponding to formula (I) as blocking agents wherein X represents an electron-attracting group, R1 and R2 independently of one another represent the radicals H, C1-C20 (cyclo)alkyl, C6-C24 aryl, C1-C20 (cyclo)alkyl ester or amide, C6-C24 aryl ester or amide, mixed aliphatic / aromatic radicals with 1 to 24 carbon atoms that can also be part of a 4- to 8-membered ring, n is an integer from 0 to 5, and B) one or more OH-functional compounds in which the OH component undergoes activation by a deposition amine component. The present invention also relates to a composite system containing two adherends bonded together with the reactive composition according to the invention.

The invention relates to compositions and methods useful for treating a variety of cosmetic conditions and dermatological disorders, where the composition includes a phenyl glycine derivative represented by the following formula:wherein, R1 and R2 are independently H, I, F, Cl, Br, OH, SH, NH2, NHNH2, alkyl, aralkyl, alkoxy, acetoxy, acyloxy group having 1 to 9 carbon atoms, and being attached at the 2, 3 or 4 position of the phenyl group, whereby when R1 and / or R2 are OH, SH, NH2, they may be acetylated or acylated with 1 to 9 carbon atoms; R3 is H, formyl, acetyl, propanoyl, acyl, alkyl, aralkyl or an aryl group having 1 to 9 carbon atoms; R4 is OH, NH2, NHOH, NHNH2, or OR; where R is an alkyl, aralkyl or aryl group having 1 to 9 carbon atoms; the H attached to any carbon or nitrogen atom may be substituted by I, F, Cl, Br, OH, SH, NH2, NHNH2, an alkyl, aralkyl, alkoxy or acyl group having 1 to 9 carbon atoms. Phenyl-glycine and its derivatives may be present as isomeric D or L, non-isomeric or racemic DL, as a free acid, salt, lactone, amide or ester form.

Disclosed herein is an injectable long-acting analgesic composition comprising: (a) a ketorolac ester derivative of formula (I),  wherein  R is a straight-chain or branched saturated or unsaturated C1-C20 aliphatic group optionally substituted with a C6-C10 aryl group; and (b) a pharmaceutically acceptable oil vehicle. The composition can provide a longer duration of action and, therefore, is suitable for use in the treatment of long-lasting pains and inflammations.

Sulfonate salts have the formula: R1COOCH2CH2CF2CF2SO3−M+ wherein R1 is alkyl, aryl or hetero-aryl, M+ is a Li, Na, K, ammonium or tetramethylammonium ion. Onium salts, oxime sulfonates and sulfonyloxyimides derived from these salts are effective photoacid generators in chemically amplified resist compositions.

The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

A thermoplastic composition includes a poly(arylene ether) and a poly(arylene ether)-polysiloxane block copolymer. The thermoplastic composition is prepared by a method that includes oxidatively copolymerizing a monohydric phenol and a hydroxyaryl-terminated polysiloxane. The method is simpler than prior methods of preparing poly(arylene ether)-polysiloxane block copolymers by linking pre-formed poly(arylene ether) and polysiloxane blocks. The method is also produces greater incorporation of polysiloxane into the poly(arylene ether)-polysiloxane block copolymer than prior methods of copolymerizing monohydric phenols and hydroxyaryl-terminated polysiloxane.

Described are agrochemical compositions which comprise of one or more one agrochemical active ingredient(s) and alkylenediol-modified polysiloxanes of the general formula (I): wherein R1 are alkyl radicals having 1 to 4 carbon atoms or aryl radicals, wherein at least 80% of the radicals R1 are methyl radicals , R2 in the molecule are identical or different and can have the following definitions: a) in which R3 is a hydrogen or alkyl radical, R4 is a hydrogen, alkyl or carboxyl radical, c is a number from 1 to 20, d is a number from 0 to 50, e is a number from 0 to 50 or b) correspond to R1, with the provisio that in the average molecule at least one radical R2 has the definition (a), a is a number from 1 to 200; b is a number from 0 to 10; and optionally one or more other agrochemically acceptable ingredients. The agrochemical compositions of the invention have enhanced efficacy, enhanced hydrolytic stability and / or decreased foaming properties.

Process for the gas-phase polymerization of olefins of the formula CH2=CHR where R is hydrogen or an alkyl or aryl radical with 1 to 8 carbon atoms carried out in one or more reactors having a fluidized or mechanically agitated bed, using a catalyst obtained by reaction of a titanium halide or haloalcoholate and optionally an electron-donor compound supported on an active Mg-dihalide with an Al-trialkyl compound and optionally an electron-donor compound, comprising the steps of:a) contacting the catalyst components in the absence of polymerizable olefin or optionally in the presence of said olefin in an amount to from up to 3 g per g of solid catalyst component;b) prepolymerizing propylene or mixtures of propylene with ethylene or an alpha-olefin to form a propylene polymer having an insolubility in xylene of at least 60% by weight, in an amount of from 5 g of polymer per g of solid catalyst component to 10% by weight of the final catalyst yield; andc) polymerizing one or more CH2=CHR olefins in the gas phase in the presence of the prepolymer-catalyst system obtained in b), while maintaining in the gas phase an alkane in a molar concentration with respect to the total gases of from 20 to 90%.

Disclosed is a fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound having a structure represented by the following general formula (A).In the formula, n indicates an integer of 1 to 10; R indicates a substituted or unsubstituted C1-C20 linear, branched or cyclic alkyl group, a substituted or unsubstituted C1-C20 linear, branched or cyclic alkenyl group, a substituted or unsubstituted C6-C15 aryl group, or a C4-C15 heteroaryl group; and a indicates 1 or 0. A photoacid generator containing the above fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound shows high sensitivity to an ArF excimer laser or the like, presents no concerns about human body accumulation, can generate an acid (photoacid) of sufficiently high acidity, and exhibits high solubility in a resist solvent and good compatibility with a resist resin.

The present invention relates to an amino-functional polysiloxane of formula (1) where each R1 is independently selected from alkyl or aryl radicals, each R2 is independently selected from hydrogen, alkyl or aryl radicals, n is selected so that the molecular weight for the functional polysiloxane is in the range of from 400 to 10,000 and R3 is a bivalent radical or —O—R3—NH—R5 is hydroxy or alkoxy, and R5 is selected from hydrogen, aminoalkyl, aminoalkenyl, aminoaryl, aminocycloalkyl radical, optionally substituted by alkyl, aryl, cycloalkyl, halogen, hydroxy, alkoxy, thioalkyl, amino, amino derivatives, amido, amidoxy, nitro, cyano, keto, acyl derivatives, acyloxy derivatives, carboxy, ester, ether, esteroxy, heterocycle, alkenyl or alkynyl and where 0 to 90% of —O—R3—NH—R5 is hydroxy or alkoxy. The present invention further relates to an epoxy-polysiloxane composition which includes an aminopolysiloxane hardener component or an amino-functional polysiloxane hardener component of formula (1), having active hydrogens able to react with epoxy groups in an epoxy resin to form epoxy polymers, and able to react with a polysiloxane to form polysiloxane polymers, wherein the epoxy chain polymers and polysiloxane polymers polymerize to form a cured epoxy-polysiloxane polymer composition.

Polycarbonates incorporating terminal carbonate groups derived from ester-substituted activated carbonates, for example terminal methyl salicyl carbonate (TMSC) derived from the use of BMSC as the activated carbonate in a transesterification process, have unfavorable properties with respect to color, hydrolytic stability and thermal stability, particularly when the polycarbonate containing such end groups is molded. The number of activated carbonate end groups formed during the melt transesterification formation of polycarbonate can be reduced, however, without sacrificing the benefits of using an activated diaryl carbonate, and without requiring a separate reaction or additional additives by reacting a dihydroxy compound with an activated diaryl carbonate in the presence of an esterification catalyst to produce a polycarbonate, wherein the molar ratio of activated diaryl carbonate to dihydroxy compound is less than 1 when expressed to at least three decimal places, for example 0.996 or less.

The present invention provides one kind of catalyst for polymerization of olefin and the catalyst includes Mg, Ti, halogen and electron donor. The electron donor is at least one kind of dialcohol ester compound.

The invention relates to the use of compounds of the formula (1) in whichR1 is C1- to C24-alkyl, C2- to C24-alkenyl or a C6- to C18-aryl radical which may be substituted by a C1- to C24-alkyl group,R2, R3 independently of one another, are hydrogen, C1- to C18-alkyl, or C8- to C7-cycloalkyl, or R2 and R3, including the nitrogen atom to which they are bonded, form a ring of 4 to 8 ring atoms, in which oxygen or nitrogen atoms may also be present in addition to carbon.A are identical or different C2- to C4-alkylene radicals,B is C1- to C7-alkylene, andn is an integer from 1-40,as gas hydrate inhibitors.

Provided is an organic electroluminescent device (organic EL device), which has improved luminous efficiency, has sufficient driving stability, and has a simple construction. The organic EL device of the present invention is an organic electroluminescent device, including a light-emitting layer and a hole-transporting layer between an anode and a cathode laminated on a substrate, in which the light-emitting layer contains a phosphorescent light-emitting dopant and an indolocarbazole compound that serves as a host material, or alternatively, the hole-transporting layer contains an indolocarbazole compound. The indolocarbazole compound is represented by the following formula (1). In the formula: A1's each represent an aromatic hydrocarbon group or an aromatic heterocyclic group, provided that at least one of A1's has a fused ring structure; and R1's each represent a hydrogen atom, an alkyl group, an alkoxy group, or an acyl group.

A catalyst used for olifin polymerizing reaction CH2=CHR, where R is hydrogen or C1-C6 alkyl or aryl, contains Mg, Ti, halogen and electron doner which may be at least one dialkoxide compound.